These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 4036700)

  • 1. Mechanisms of action of absorbable hypolipidemic drugs.
    Sirtori CR
    Adv Exp Med Biol; 1985; 183():241-52. PubMed ID: 4036700
    [No Abstract]   [Full Text] [Related]  

  • 2. Apolipoprotein C-II and lipoprotein lipase activity.
    Catapano AL
    Ric Clin Lab; 1982; 12(1):35-40. PubMed ID: 7046021
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue lipoprotein lipase activity and its action in lipoprotein metabolism.
    Cryer A
    Int J Biochem; 1981; 13(5):525-41. PubMed ID: 7016622
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of action of gemfibrozil on lipoprotein metabolism.
    Saku K; Gartside PS; Hynd BA; Kashyap ML
    J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of C-apolipoproteins in the metabolism of triglyceride-rich lipoproteins.
    Reckless JP; Stocks J; Holdsworth G
    Clin Sci (Lond); 1982 Feb; 62(2):125-9. PubMed ID: 7053911
    [No Abstract]   [Full Text] [Related]  

  • 6. [The mechanism of action of hypolipidemic drugs].
    Scheen AJ
    Rev Med Liege; 1997 Jun; 52(6):445-6. PubMed ID: 9289779
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the degradation of human very low density lipoproteins by human milk lipoprotein lipase.
    Wang CS; Weiser D; Alaupovic P; McConathy WJ
    Arch Biochem Biophys; 1982 Mar; 214(1):26-34. PubMed ID: 7082001
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of gemfibrozil administration on very low density lipoprotein receptor mRNA levels in rabbits.
    Matsuoka N; Jingami H; Masuzaki H; Mizuno M; Nakaishi S; Suga J; Tanaka T; Yamamoto T; Nakao K
    Atherosclerosis; 1996 Oct; 126(2):221-6. PubMed ID: 8902147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on duck serum lipoproteins. VIII. Studies on biological activity and metabolism of HDL-apo C II in vitro].
    Li XZ; Wang KQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Apr; 9(2):89-94. PubMed ID: 2955931
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
    Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S
    Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein CII and lipoprotein lipase in human nephrotic syndrome.
    Kashyap ML; Srivastava LS; Hynd BA; Brady D; Perisutti G; Glueck CJ; Gartside PS
    Atherosclerosis; 1980 Jan; 35(1):29-40. PubMed ID: 7370086
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C.
    Catapano AL; Capurso A; Kinnunen PK
    Artery; 1981; 9(2):87-95. PubMed ID: 7295047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein lipase: mechanism of action and role in lipoprotein metabolism.
    Quinn D; Shirai K; Jackson RL
    Prog Lipid Res; 1983; 22(1):35-78. PubMed ID: 6346343
    [No Abstract]   [Full Text] [Related]  

  • 15. The competitive inhibition of C-II dependent lipoprotein lipase activity by heparin.
    Posner I
    Acta Cient Venez; 1983; 34(2):118-23. PubMed ID: 6544540
    [No Abstract]   [Full Text] [Related]  

  • 16. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
    Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
    Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization, structure and reaction mechanism of enzymes involved in plasma lipoprotein metabolism].
    Ikeda Y; Takagi A
    Tanpakushitsu Kakusan Koso; 1987 Dec; 32(13):1529-45. PubMed ID: 3444891
    [No Abstract]   [Full Text] [Related]  

  • 18. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro.
    Jahn CE; Osborne JC; Schaefer EJ; Brewer HB
    Eur J Biochem; 1983 Mar; 131(1):25-9. PubMed ID: 6403350
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil.
    Huff MW; Telford DE; Edmonds BW; McDonald CG; Evans AJ
    Biochim Biophys Acta; 1993 Dec; 1210(1):113-22. PubMed ID: 8257713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.